KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Pharmaceuticals (ACAD) Non-Current Assets (2016 - 2025)

Acadia Pharmaceuticals has reported Non-Current Assets over the past 16 years, most recently at $502.1 million for Q4 2025.

  • Quarterly results put Non-Current Assets at $502.1 million for Q4 2025, up 101.29% from a year ago — trailing twelve months through Dec 2025 was $1.3 billion (up 59.76% YoY), and the annual figure for FY2025 was $502.1 million, up 101.29%.
  • Non-Current Assets for Q4 2025 was $502.1 million at Acadia Pharmaceuticals, up from $254.3 million in the prior quarter.
  • Over the last five years, Non-Current Assets for ACAD hit a ceiling of $502.1 million in Q4 2025 and a floor of $76.8 million in Q3 2021.
  • Median Non-Current Assets over the past 5 years was $141.8 million (2023), compared with a mean of $164.8 million.
  • Biggest five-year swings in Non-Current Assets: surged 252.55% in 2021 and later dropped 2.95% in 2022.
  • Acadia Pharmaceuticals' Non-Current Assets stood at $82.3 million in 2021, then decreased by 2.95% to $79.9 million in 2022, then soared by 66.3% to $132.8 million in 2023, then surged by 87.79% to $249.4 million in 2024, then soared by 101.29% to $502.1 million in 2025.
  • The last three reported values for Non-Current Assets were $502.1 million (Q4 2025), $254.3 million (Q3 2025), and $265.0 million (Q2 2025) per Business Quant data.